Dermata Cash from 2010 to 2025

DRMAW Stock  USD 0.02  0.00  0.000005%   
Dermata Therapeutics Cash yearly trend continues to be fairly stable with very little volatility. Cash is likely to outpace its year average in 2025. Cash is the total amount of money in the form of currency that Dermata Therapeutics Warrant has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2010-12-31
Previous Quarter
3.2 M
Current Value
5.5 M
Quarterly Volatility
2.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dermata Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dermata Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 237.1 K, Depreciation And Amortization of 9.7 M or Interest Expense of 111.4 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0014. Dermata financial statements analysis is a perfect complement when working with Dermata Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Dermata Therapeutics Correlation against competitors.
For more information on how to buy Dermata Stock please use our How to Invest in Dermata Therapeutics guide.

Latest Dermata Therapeutics' Cash Growth Pattern

Below is the plot of the Cash of Dermata Therapeutics Warrant over the last few years. Cash refers to the most liquid asset of Dermata Therapeutics, which is listed under current asset account on Dermata Therapeutics Warrant balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Dermata Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Dermata Therapeutics account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Dermata Therapeutics' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dermata Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Dermata Cash Regression Statistics

Arithmetic Mean3,351,120
Geometric Mean2,607,573
Coefficient Of Variation81.45
Mean Deviation2,075,432
Median1,991,802
Standard Deviation2,729,357
Sample Variance7.4T
Range10.3M
R-Value0.57
Mean Square Error5.4T
R-Squared0.32
Significance0.02
Slope324,666
Total Sum of Squares111.7T

Dermata Cash History

20255.5 M
20243.2 M
20237.4 M
20226.2 M
202110.8 M
2020530.4 K

Other Fundumenentals of Dermata Therapeutics

Dermata Therapeutics Cash component correlations

About Dermata Therapeutics Financial Statements

Dermata Therapeutics investors use historical fundamental indicators, such as Dermata Therapeutics' Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dermata Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash3.2 M5.5 M
Cash And Short Term Investments3.2 B3.3 B
Change In Cash-4.3 B-4.1 B
Free Cash Flow-11.2 B-10.6 B
Begin Period Cash Flow7.4 B7.8 B
Other Cashflows From Financing Activities1.1 K1.1 K
Other Non Cash Items466.4 M489.7 M
Total Cash From Operating Activities-11.2 B-10.6 B
Total Cash From Financing Activities6.9 M7.7 M
End Period Cash Flow3.2 B3.3 B
Free Cash Flow Yield-5.4 K-5.1 K
Operating Cash Flow Per Share-7.3 K-6.9 K
Free Cash Flow Per Share-7.3 K-6.9 K
Cash Per Share2.1 K2.2 K
Cash Ratio 1.60  2.85 
Cash Conversion Cycle-135.9 K-142.7 K
Cash Flow Coverage Ratios(1.02)(1.07)
Cash Flow To Debt Ratio(1.02)(1.07)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Dermata Stock Analysis

When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.